Study Summary
This trial aims to test the effects of tart cherry supplements on MetSyn, a growing health concern linked to cardiovascular diseases & type II diabetes, with treatment including exercise & weight loss.
- Metabolic Syndrome
Treatment Effectiveness
Effectiveness Progress
Study Objectives
7 Primary · 0 Secondary · Reporting Duration: baseline, 30 days post supplementation, 60 days post supplmentation
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
tart cherry
1 of 2
placebo
1 of 2
Experimental Treatment
Non-Treatment Group
30 Total Participants · 2 Treatment Groups
Primary Treatment: tart cherry · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 60 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the cumulative participant count for this investigation?
"Indeed, the data posted to clinicaltrials.gov clearly states that this trial is still recruiting patients as of November 7th 2022. It was initially published on April 6th and requires 30 individuals from a single medical centre." - Anonymous Online Contributor
What criteria must an individual fulfill in order to be accepted into this experiment?
"This trial seeks to recruit thirty individuals with metabolic syndrome, ranging from 18 to 60 years of age. To qualify for the study, participants must have a waist circumference higher than 40 inches (if male) or above 35 inches (female), blood pressure greater than 130/80 mmHg or be taking medication for high blood pressure, triglycerides levels surpassing 150 mg/dL and HDL below 40mg/dl in men and 50mg/dl in women; additionally, fasting glucose should be between 100-126 mg/dL or diagnose as pre-diabetic." - Anonymous Online Contributor
Is this clinical investigation enrolling senior citizens?
"This clinical trial is geared towards patients between 18 and 60 years of age; however, there are other trials for those under 18 (382) or over 65 (1045)." - Anonymous Online Contributor
Are additional participants being admitted to this research endeavor?
"Data collected on clinicaltrials.gov confirms that this trial is still actively recruiting participants, having been initially posted on April 6th 2022 and last updated November 7th of the same year." - Anonymous Online Contributor